Susan Hasty, Publisher
Table of Contents . . . November 7th, 2004
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Preventive Medicine Week | Other Publications
Case Western Reserve Univ. - Study identifies target for preventing sexual transmission of HIV
Christie Hospital NHS Trust - Inconsistent psychosocial outcomes among cancer services thwart comparison
Discovery Laboratories, Inc. - MAA submitted to market Surfaxin in Europe
Sovereign Specialty Chemicals, Inc. - Chemical company signs agreement to be acquired by Henkel Corporation
305-575-6043 - FDA gives final approval for Brimonidine Tartrate Ophthalmic Solution, 0.2% ANDA
3M Health Information - Maryland adopts classification system for payment of healthcare services
Aachen University - RANTES haplotypes influence the response to chronic hepatitis C therapy
Aalborg Hospital - Esophagus shear modulus of elasticity studied in rat model
Acambis, Inc. - U.S. HHS awards $232 million in biodefense contracts for vaccine development
Addenbrookes Hospital, Cambridge - Peptide-HSP70 complexes generate cytolytic T-lymphocyte responses
Advanced Nutraceuticals, Inc. - Nutraceuticals company reports release of escrow funds
Aerogen, Inc. - Device companies announce distribution agreement for nebulizer system
Affymax, Inc. - Phase I trial of Hematide initiated
Aksys, Ltd. - Milestone achieved in home dialysis
Allergy Therapeutics - Pharmaceutical company raises GBP 16M, seeks admission to AIM
Amarin Corporation plc - Neuroscience company raises $12.75M in private placement
American Academy of Allergy, Asthma & Immunology - Study: Anti-dust mite covers effective in reducing allergens
American Diabetes Association - Safe at School campaign launched for kids with diabetes
American Spinal Injury Association - Actor brought strength, larger-than-life clout to spinal cord research
Amisys Synertech Inc. - Health plan completes migration to payer software application
Argos Therapeutics, Inc. - Company changes name and prepares for HIV vaccine trial
AspenBio, Inc. - Biotech firm appoints David Welch to the board of directors
Assaf-Harofeh Medical Center - Tezosentan at 1-25 mg/h improves hemodynamics and reduces B natriuretic peptide
Auvergne University - Impaired muscle protein synthesis linked to S6K1 dysregulation
Becton, Dickinson and Co. - Pharmaceutical company announces plan to sell Clontech
BioSante Pharmaceuticals, Inc. - Update provided on Bio-E-Gel phase III trial
Biofrontera, AG - DNAPrint genomics to acquire majority ownership in German pharmaceutical company
Biotel, Inc. - Device maker reports company profitability
Boston Scientific Corporation - Bionics cochlear auditory implants recalled worldwide
Bovine Spongiform Encephalopathy - Japan confirms 14th case of mad cow disease
Brady Urology Health Cntr. - Androgen receptor expression inversely correlates with pathologic, tumor stage
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.